Detection of COVID-19 Decompensation

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 5, 2020

Primary Completion Date

September 9, 2021

Study Completion Date

September 9, 2021

Conditions
Covid19
Interventions
DEVICE

Use of the pinpointIQ solution (physIQ, Inc.)

Patients are monitored for 28 days post COVID19 diagnosis or COVID19 post-hospitalization discharge using the pinpointIQ solution.

Trial Locations (4)

60210

NorthShore University HealthSystem, Evanston

60612

Rush University Medical Center, Chicago

University of Illinois Hospital and Health Sciences System, Chicago

77004

University of Texas Health, Houston

All Listed Sponsors
collaborator

National Institute for Biomedical Imaging and Bioengineering (NIBIB)

NIH

collaborator

National Cancer Institute (NCI)

NIH

collaborator

University of Illinois at Chicago

OTHER

lead

physIQ, Inc.

INDUSTRY

NCT04575532 - Detection of COVID-19 Decompensation | Biotech Hunter | Biotech Hunter